INS and Stroke: Patients who used both insulin and OAD (4.3%, 95% CI 3.2 ~ 5.5%) had higher 10-year risk of nonfatal stroke (P = 0.043), compared to those under OAD monotherapy (3.0%, 95% CI 2.7 ~ 3.4%).